RNAZ logo
RNAZ NASDAQ US

TransCode Therapeutics, Inc. - Common Stock

Healthcare · Biotechnology Website · IPO Apr 2021
$8.60
▼ $-0.09 (-1.04%)
Vol 2K
2
Quality Score
fail
Mkt Cap
$6.3M
ROE
-356.3%
D/E
0.00
Beta
1.54
52W
$6–$468

Wall Street Consensus

7 analysts · Jun 2025
2
Strong Buy
4
Buy
1
Hold
0
Sell
0
Strong Sell
85.7%
Buy Rating

Price Chart

Similar Stocks

BOLT
Bolt Biotherapeutics Inc
$10.5M
APRE
Aprea Therapeutics Inc
$6.0M
GRDX
GridAI Technologies Corp
CELZ
Creative Medical Technology Holdings Inc
$5.1M
PMCB
PharmaCyte Biotech Inc
$7.3M
SYBX
Synlogic Inc
$13.1M
LIMN
Liminatus Pharma Inc
$16.5M

Earnings

Beat rate: 50.0%
Quarter EPS Est EPS Act Surprise
Dec 2024 $-91.68 $-150.64 $-58.96
Sep 2024 $-461.82 $-147.84 +$313.98
Jun 2024 $-546.64 $-665.28 $-118.64
Mar 2024 $-659.74 $-498.96 +$160.78

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -309.8% -309.8% -309.8% -309.8% -309.8% -356.3%
P/E (TTM) — — — — — —
Net Margin — — — — — —
Gross Margin — — — — — —
D/E Ratio 0.00 0.00 0.00 0.00 0.00 0.00
Current Ratio 5.27 5.27 5.27 5.27 5.27 1.60

Key Ratios

ROA (TTM)
-319.4%
P/B
2.5
EPS (TTM)
$-352.74
CF/Share
$-13.32
52W High
$468.44
52W Low
$6.15
$6.15 52-Week Range $468.44

How does RNAZ compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

RNAZ AAPG ABEO ABOS ABP

RNAZ valuation vs Biotechnology peers

P/E ratio
—
▼ 0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼ 0% below peers (12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
2.5
▲ 2% above peers (2.5)
vs Peers
vs Industry
Fair value
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

RNAZ profitability vs Biotechnology peers

ROE
-356.3%
▼ 429% below peers (-67.3%)
vs Peers
vs Industry
Weak
Net margin
—
▼ 0% below peers (-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼ 0% below peers (78.6%)
vs Peers
vs Industry
In line
ROA
-319.4%
▼ 584% below peers (-46.7%)
vs Peers
vs Industry
Weak

RNAZ financial health vs Biotechnology peers

D/E ratio
0.0
▼ 0% below peers (0.0)
vs Peers
vs Industry
Low debt
Current ratio
1.6
▼ 64% below peers (4.4)
vs Peers
vs Industry
Low liquidity
Beta
1.5
▲ 59% above peers (1.0)
vs Peers
vs Industry
More volatile

RNAZ fundamentals radar

RNAZ Peer median Industry

RNAZ profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

RNAZ vs peers: key metrics

Latest News

No related news yet